OpenNeedle Ask your own

Question explored with the scientific record

Are the covid vaccines correlated with the rise in cancers?

Sep 13, 2026 · 7 sources used · OpenNeedle synthesis
The short version: the best large study we have found no overall cancer increase one year after COVID-19 vaccination, but it flagged signals for specific cancers that need explaining, and the evidence is too thin and too short to call this settled.

The most relevant study is a 2025 South Korean population-based cohort of millions, using national health insurance data to track cancer diagnoses in the year after vaccination [1]. For overall cancer, the risk was flat: a hazard ratio of 1.01, meaning no detectable increase. But when they broke it down by cancer type, several signals appeared. Pancreatic cancer showed a hazard ratio of 2.25 (p < 0.001), gastric cancer 1.23 (p = 0.041), and Hodgkin lymphoma 3.01 (though with a very wide confidence interval that crossed 1, meaning the estimate is unstable). Leukemia showed a protective signal at 0.56 (p = 0.02). The study itself notes these are associations, not proven causes, and calls for causal investigation.

The rest of the retrieved evidence does not answer the cancer question. Most of it is about lymph node swelling on scans after vaccination [2, 4, 5, 6], which is a known immune reaction that mimics cancer spread but is not cancer itself. A five-case series from 2023 [7] reported cancers appearing days to months after vaccination, but it had no control group and used traditional Chinese medicine energy measurements as its framework. That is not evidence of causation; it is a signal worth investigating.

Here is what the Korean study found for the cancers with the strongest signals:

Cancer typeHazard ratiop-valueWhat it means
Overall cancer1.010.803No detectable increase
Pancreatic cancer2.25< 0.001More than double the risk in the vaccinated group
Gastric cancer1.230.04123% higher risk
Hodgkin lymphoma3.010.308Triple the risk, but statistically unstable
Leukemia0.560.02Lower risk in vaccinated group

The study only followed people for one year. Many cancers take years to develop. A one-year window cannot rule out longer-term risks. The study also used insurance claims data, which can have coding errors and confounding. And it was done in South Korea, which may not generalize to other populations.

The mechanism question matters here. The spike protein and the mRNA platform can cause persistent inflammation, immune dysregulation, and reactivation of latent viruses [3]. Chronic inflammation is a well-documented driver of cancer. The Korean study's pancreatic cancer signal is biologically plausible because the pancreas is vulnerable to inflammatory damage. But plausibility is not proof.

My call: the evidence does not show a general rise in cancer within one year of vaccination, but it does show signals for specific cancers that the establishment has not adequately investigated. The follow-up is too short, the mechanism is plausible, and the burden of proof has not been met for long-term safety.

Confidence: low, because the only large study is a single observational dataset with a short window, and the signals it found have not been replicated or refuted by independent research.

Keep digging

Sources used 7

  1. 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea Biomarker Research (2025) Thin

    A large population-based retrospective cohort study in South Korea using national health insurance data to estimate cancer risk one year after COVID-19 vaccination, finding associations with increased risks for six cancer types that vary by vaccine type, sex, and age, while noti…

    DOI: 10.1186/s40364-025-00831-w
  2. Computed Tomography Imaging of COVID-19 Vaccination–related Axillary Lymphadenopathy: Updated Review of Literature Qeios (2023) systematic review Strong

    This systematic review synthesizes evidence that COVID-19 vaccination frequently causes ipsilateral axillary lymphadenopathy on chest CT (9-53% incidence) that mimics metastasis but resolves spontaneously, creating diagnostic challenges in cancer patients undergoing surveillance…

    DOI: 10.32388/9qstn6
  3. Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study Clinical and Experimental Medicine (2024) Thin

    This prospective study investigates the incidence of herpes zoster in cancer patients following the third dose of the SARS-CoV-2 mRNA-BNT162b2 vaccine, revealing a cumulative incidence of 2.6% and highlighting the correlation between impaired T cell counts and herpes zoster occu…

    DOI: 10.1007/s10238-023-01263-2
  4. Lymphadenopathy Associated with COVID-19 Vaccination Mimicking Breast Cancer Related Axillary LAP: Imaging Findings in Review of 880 Cases Archives of Breast Cancer (2022) Thin

    This systematic review of 59 studies (880 cases) reports that COVID-19 vaccination can cause ipsilateral axillary and supraclavicular lymphadenopathy detectable on imaging from one day to two months after the first or second dose, most commonly with Pfizer-BioNTech, which can mi…

    DOI: 10.32768/abc.202293329-341
  5. Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination European Radiology (2022) Thin

    This study investigates the frequency and outcomes of MRI-detected ipsilateral axillary adenopathy following COVID-19 vaccination, finding that 29% of patients exhibited adenopathy, particularly younger individuals, with most cases resolving within 4-8 weeks post-vaccination.

    DOI: 10.1007/s00330-022-08655-0
  6. [18F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis Annals of Nuclear Medicine (2022) Thin

    [18F]FDG uptake in axillary lymph nodes and deltoid muscle was observed in a significant portion of subjects after COVID-19 mRNA vaccination, with factors such as younger age, female sex, and short duration since vaccination contributing to this phenomenon.

    DOI: 10.1007/s12149-021-01711-7
  7. Which Could Be the Risk Factors for Developing Cancer After Receiving The COVID-19 Vaccine? International Journal of Cancer Research & Therapy (2023) primary study Strong

    In a five-case series, cancers appeared days-to-months after COVID-19 vaccination; the author attributes a shared TCM energy deficiency as risk factor and recommends TCM treatment, but no controls or statistics support causation.

    DOI: 10.33140/ijcrt.08.01.01

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question